[1] | Journal of Hepatology|Protein phosphatase 6 regulates metabolic dysfunction-associated steatohepatitis via the mTORC1 pathway[J]. Journal of Clinical Hepatology, 2025, 41(2): 364-364. doi: 10.12449/JCH2502.gwqkjpwzjj2 |
[2] | Hepatology International|Functional B cell deficiency promotes intrahepatic HBV replication and impairs the development of anti-HBV T cell responses[J]. Journal of Clinical Hepatology, 2024, 40(12): 2360-2360. doi: 10.12449/JCH2412.gwqkjpwzjj1 |
[3] | Wentao XIE, Kangkang YU, Qi CHENG, Ning LI. Mechanism of microRNA-223-3p inhibiting hepatic stellate cell activation by targeting microtubule-associated protein 1B[J]. Journal of Clinical Hepatology, 2023, 39(12): 2845-2850. doi: 10.3969/j.issn.1001-5256.2023.12.015 |
[4] | Gerui ZHU, Yani PI, Jing WANG, Kai HUANG, Yuan PENG, Gaofeng CHEN, Chenghai LIU, Yanyan TAO. Efficacy of Astragali Radix extract in treatment of a mouse model of aristolochic acid Ⅰ-induced liver and renal injury by regulating the IL-6/STAT3 signaling pathway[J]. Journal of Clinical Hepatology, 2023, 39(8): 1903-1910. doi: 10.3969/j.issn.1001-5256.2023.08.020 |
[5] | Journal of Gastroenterology and Hepatology|Farnesoid X receptor is an important target for the treatment of disorders of bile acid and fatty acid metabolism in mice with nonalcoholic fatty liver disease combined with cholestasis[J]. Journal of Clinical Hepatology, 2023, 39(11): 2523-2523. doi: 10.3969/j.issn.1001-5256.2023.11.gwjpwzjj1 |
[6] | Hepatology|Gastrodin improves nonalcoholic steatohepatitis by activating the AMPK signaling pathway[J]. Journal of Clinical Hepatology, 2022, 38(2): 319-319. doi: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj2 |
[7] | Hepatology|Macrophage-specific fibroblast growth factor 12 promotes liver fibrosis progression in mice[J]. Journal of Clinical Hepatology, 2022, 38(8): 1885-1885. doi: 10.3969/j.issn.1001-5256.2022.08.gwjpwzjj2 |
[8] | Song XUE, Gaobo HUANG, Xiaofei YANG, Ye ZHANG, Yu LI. Influence of interleukin-6 on the expression and function of programmed death-1 in CD8+ T cells from patients with hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(10): 2332-2337. doi: 10.3969/j.issn.1001-5256.2021.10.015 |
[9] | Shengnan DU, Jingjing GAO, Tao WANG, Yuanye JIANG, Qin CAO. Value of circular RNA in the diagnosis and treatment of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(11): 2684-2688. doi: 10.3969/j.issn.1001-5256.2021.11.043 |
[10] | Xinyu AN, Lingxi HU, Jie QIAO, Rongqi WANG, Yuemin NAN. Role of microRNAs in the development and progression of nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2021, 37(12): 2963-2966. doi: 10.3969/j.issn.1001-5256.2021.12.048 |
[11] | Jie ZHANG, Xuefeng MA, Yifen WANG, Mengke WANG, Likun ZHUANG, Shousheng LIU, Yongning XIN. Hepatocyte-specific TM6SF2 knockout aggravates hepatic steatosis in mice with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(11): 2612-2616. doi: 10.3969/j.issn.1001-5256.2021.11.024 |
[12] | Zhang ShiWan, Yu XueQin, Chen Fang, Mei YiHan, Mei XiaoPing. Biological characteristics of exosome microRNA and its role in the development and progression of liver fibrosis[J]. Journal of Clinical Hepatology, 2020, 36(9): 2083-2086. doi: 10.3969/j.issn.1001-5256.2020.09.039 |
[13] | Mai JingYin, Chen TianYang, Cheng Yang. Changes in microRNA expression profile in the liver of mice with nonalcoholic fatty liver disease induced by high-fat diet[J]. Journal of Clinical Hepatology, 2017, 33(12): 2372-2375. doi: 10.3969/j.issn.1001-5256.2017.12.023 |
[14] | Zhao Rui, Li Juan, Wang Liang, Kong Yin, Ding Jie, Wang JuanXia, Li GuangMing, Zhang LingYi. Expression of hepcidin and interleukin-6 and their correlation in liver inflammation process in a rat model of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(9): 1774-1777. doi: 10.3969/j.issn.1001-5256.2017.09.030 |
[15] | Guo JinSheng. Recent perspectives on mechanisms of liver fibrogenesis: microRNA and cell autophagy [J]. Journal of Clinical Hepatology, 2013, 29(5): 324-326. |
[16] | Liu JiaXiu, Xu Bin, Liu XingXiang, Li GuiZhen. Correlation between HBVDNA load and IFN-γ and IL-6 secreted by PMBC in patients with chronic hepatitis B [J]. Journal of Clinical Hepatology, 2010, 26(5): 510-512. |
[17] | Wang ChunPing, Zhang Ming. Evaluation of leptin receptor Gln223Arg polymorphism in patients with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2008, 24(3): 194-196. |
[18] | You Zhen, Zhang XueChun. The relationship of TNF-α、IL-6 in portal vein and hepatic damage in SAP rats[J]. Journal of Clinical Hepatology, 2004, 20(5): 295-296. |
[19] | Zhen YanBo, Liu XiaoHua, Zhao Ping. Influence of matrine on serum levels of IL-6, IL-8 in patients with liver fibrosis induced by chronic hepatitis B.[J]. Journal of Clinical Hepatology, 2004, 20(2): 87-88. |
[20] | Kong Li, Li BingShun, Zhen Zhen, Liu JinXing. Levels of IL-6 and IL-8 in the patients with hepatitis and clinical siginificance[J]. Journal of Clinical Hepatology, 2002, 18(3): 170-172. |